Ten more years, but at what cost? What the EU's organic equivalence extension really means for New Zealand

What the EU equivalence proposal actually says

The Commission's reasoning is candid. New equivalence agreements are being negotiated with multiple third countries simultaneously, and the EU has acknowledged that not all of those negotiations will be completed by the end of 2026. The extension is described in the proposal itself as "necessary and urgent" to avoid disruptions in trade. It is a procedural fix to a logistical problem at the Commission's end, not a strategic gift to exporting nations.

What sits alongside the extension is the part of the proposal that ought to be commanding more sector attention than the date itself. The Commission has also proposed to restrict the use of the EU organic logo on products imported from equivalence countries. Under the change, products from countries like New Zealand would only be permitted to carry the EU organic logo if they meet additional EU production requirements — including bans on hydroponic production and stricter animal welfare standards. Products that meet equivalence but not these additional requirements could still be sold as "organic" in the EU and could still use third country logos and the words "organic", "bio" or "eco" — but not the EU mark itself.

This change is the Commission's response to the European Court of Justice ruling in Herbaria Krauterparadies (Case C-240/23), handed down in October 2024. The Court found that the EU organic logo is intended to signal full compliance with EU rules, not equivalence, and that allowing equivalent-but-different products to carry the same logo risks misleading consumers and creating unfair competition. IFOAM-Organics International has criticised the Commission's proposed response as undermining the principle of equivalence it claims to uphold. That argument will play out through the EU legislative process over the next year or more.

The practical effect for New Zealand, if the proposal is adopted as drafted, is twofold. Market access continues — for a decade. But the visible badge of organic credibility on European shelves, the EU leaf, may become harder to use for NZ product unless NZ standards are adjusted to mirror EU production rules in specific areas.

The asymmetry at home

This is where the New Zealand regulatory picture becomes harder to defend on its own terms.

The Organic Products and Production Act 2023 took more than a decade of sector advocacy to pass. It was enacted in April 2023. The Organic Products and Production Regulations 2025 and Organic Standards Regulations 2025 were finally released in late September 2025 — more than two and a half years after the Act passed. Cost recovery for some operators is scheduled to begin in mid-2026. The National Organic Standard itself remains in a state of ongoing refinement, with supplementary notices still being developed. For operators navigating the cost implications, see our certification cost guide.

Twelve years of negotiation. Three years of post-enactment consultation. A regulatory system that operators are now being asked to fund without yet knowing the full shape of what they are paying for.

Meanwhile, the Gene Technology Bill — introduced in December 2024, identified in the coalition government's Q4 Action Plan as a priority deliverable — has moved through Parliament on a fundamentally different timetable. Public consultation drew over 14,500 written submissions, the overwhelming majority opposed. Of approximately 1,500 requests to present oral submissions, only around 400 were granted, each given five to ten minutes. The Health Select Committee reported back in October 2025 recommending the Bill proceed. Although cross-party negotiations have slowed final passage, the Bill is structurally designed to come into force in stages, with key provisions backstopped to commence within two years of Royal assent whether or not the implementing regulations are ready.

The Regulatory Impact Statement prepared by MBIE in July 2024 acknowledged the consequences of this pace. It noted that the compressed timetable "may mean options, impacts, and consequences were not (or not fully) considered." It also identified "unquantified costs to organic/non-GMO primary producers" as a known but unmeasured impact of the reform.

That gap in MBIE's analysis is not hypothetical. In November 2024, Organics Aotearoa New Zealand commissioned NZIER to provide the economic analysis MBIE had not. The resulting report, Potential costs of regulatory changes for gene technology by Dr Bill Kaye-Blake and Thomas Hughes, estimated that the environmental release of GMOs in New Zealand could reduce primary sector exports by $10 billion to $20 billion annually, against a current food and fibre export base of more than $54 billion. The NZIER analysis estimated that New Zealand's clean-green brand earns exports a 59 percent value premium, and organic-labelled products an additional 39 percent. The report's authors explicitly noted that in twenty-plus years of advising government, they had not previously seen a regulatory change of this scale proposed without supporting economic analysis from the responsible agency.

There is no legal obligation on the Crown to bring an Act into force within a defined timeframe unless the Act itself prescribes one. The OPPA does not. The Gene Technology Bill does — a two-year backstop on its substantive provisions. The contrast is not unlawful. It is, however, a clear statement of legislative priority. One reform was given a structural deadline. The other was not.

Why this combination matters

Set the two threads side by side and the regulatory picture becomes coherent in a way that should concern anyone with capital, reputation, or supply chain exposed to New Zealand's clean-green positioning.

New Zealand operators are being asked to absorb cost recovery for an organic regulatory system whose external rationale — EU equivalence — has just been extended by a decade by the EU itself. At the same time, the visible market signal that justifies the premium price of NZ organic product on European shelves may be restricted unless our standards are tightened. And in parallel, a Gene Technology Bill is being progressed whose own RIS concedes that costs to the organic and non-GMO primary sector have not been quantified — a gap that independent analysis commissioned by the sector has now placed in the order of $10–$20 billion annually.

The economic exposure here is not abstract. New Zealand's organic export sector is part of a broader clean-green, non-GMO positioning that underpins price premiums across primary exports well beyond certified organic — dairy, meat, wine, horticulture, infant formula. Whether the realised loss from the release of GMOs would land at the lower or upper end of NZIER's range, as OANZ Chief Executive Tiffany Tompkins observed, "the main takeout from it was we have a lot to lose, whether that's $1 billion or $10 billion or $20 billion to lose — there is a loss." That order of magnitude is large enough that the absence of an economic impact assessment from MBIE is not a minor procedural gap. It is a material absence in the regulatory analysis underpinning a Bill that has been advanced under accelerated timelines.

The EU extension changes the urgency on one side of this equation without changing it on the other. There is now more time to finish OPPA implementation properly. There is no more time, and arguably less, to ensure GE reform does not undermine the market access that OPPA exists to protect.

What the sector should be asking for

Four questions follow from this, and they are worth putting to MPI, MBIE, and the responsible Ministers directly.

A sector worth defending properly

None of this argues against modernising New Zealand's regulatory frameworks. It argues for coherence. Two reforms passing through Parliament in the same period, affecting overlapping sectors and shared international market positioning, should be capable of being assessed together. The EU's extension gives New Zealand the time to do that work. Whether that time is used well, or simply absorbed as relief, is the question the sector now has to push.

The organic sector has spent more than a decade asking for protection through regulation. It has spent the last three years waiting for the detail. The least it can ask now, with ten more years on the clock, is that the regulation it has been waiting for is not quietly compromised by the regulation that came after it.

Frequently Asked Questions

References